First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.1601 USD
Updated: Apr 30, 2024

Sonoma Pharmaceuticals Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sonoma Pharmaceuticals Inc
Income from Continuing Operations Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Income from Continuing Operations
-$5.1m
CAGR 3-Years
-20%
CAGR 5-Years
18%
CAGR 10-Years
2%
Johnson & Johnson
NYSE:JNJ
Income from Continuing Operations
$18.7B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Income from Continuing Operations
$8B
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Income from Continuing Operations
$2.2B
CAGR 3-Years
-32%
CAGR 5-Years
-8%
CAGR 10-Years
-15%
Merck & Co Inc
NYSE:MRK
Income from Continuing Operations
$377m
CAGR 3-Years
-56%
CAGR 5-Years
-43%
CAGR 10-Years
-22%
Eli Lilly and Co
NYSE:LLY
Income from Continuing Operations
$5.2B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
1%

See Also

What is Sonoma Pharmaceuticals Inc's Income from Continuing Operations?
Income from Continuing Operations
-5.1m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Income from Continuing Operations amounts to -5.1m USD.

What is Sonoma Pharmaceuticals Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
2%

Over the last year, the Income from Continuing Operations growth was 25%. The average annual Income from Continuing Operations growth rates for Sonoma Pharmaceuticals Inc have been -20% over the past three years , 18% over the past five years , and 2% over the past ten years .